Vertex Pharmaceuticals biopharmaceuticals

Vertex Pharmaceuticals is a leading global biotechnology company. The image shows the Jeffrey Leiden Center for Cell and Genetic Therapies in Boston, Massachusetts. Originally founded in 1989 in Cambridge, Massachusetts, the company has grown into a major international player in the development of specialized medicines for serious diseases such as cystic fibrosis, sickle cell disease, and beta thalassemia.

While corporate headquarters and significant research activities are based in the United States, Vertex operates globally and utilizes a widespread manufacturing and distribution network to serve patients worldwide. The brand remains independent as a publicly traded company on the NASDAQ exchange, maintaining its corporate identity and mission as its own ultimate owner.